#News for #Investors and #Media: We're at ASCO24, to share our late-breaking research from a phase III clinical trial evaluating one of our #bloodcancer therapies. Learn more: https://gsk.to/3R6cN4r
About us
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
- Website
-
http://www.gsk.com
External link for GSK
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Brentford, Middlesex
- Type
- Public Company
- Specialties
- Pharmaceutical products and Vaccines
Locations
Employees at GSK
Updates
-
We’re at #ASCO24 asking participants to add their perspectives to our #GSKdata visualisation wall to help shape the future of oncology treatment. How do you think the community answered so far? What is the most important step we can take to improve patient outcomes in cancer? Learn more: https://gsk.to/4e3WvCY
This content isn’t available here
Access this content and more in the LinkedIn app
-
We’re at #ASCO24 in Chicago, the most significant gathering of oncology professionals worldwide. Our Senior Vice President, Global Head Oncology R&D, Hesham Abdullah, is here and shares his perspective from day 1. Learn more: https://gsk.to/4aFUQjX
-
From sleeping to breathing to working and socialising, living with chronic rhinosinusitis with #NasalPolyps (CRSwNP) affects many parts of life. This is why we are determined to develop solutions that bring meaningful improvements to those who need them. We're at #EAACI2024 where we bring together deep understanding of the immune system with our decades of expertise and ongoing innovation in the field of respiratory disease. Eduardo Genofre, VP of Global Medical Affairs, shares the focus of our research: Learn more here: https://gsk.to/3yA2Fub
-
Through our research, we dedicated to improving outcomes for people like Carmen, Alex and Thomas who are affected by cancer. Learn more about the latest updates in our oncology research, which we’ll be sharing at #ASCO24: https://gsk.to/3KlvHQY
-
Colorectal cancer affects millions worldwide, yet the options for those in advanced stages are limited. That's why our research is focused on improving outcomes for people living with this disease. Learn more: https://gsk.to/4bPn0tY #ASCO24
-
#Antimicrobialresistance is widely recognised, as an urgent global public health threat, and is already having a significant impact on public health around the world.
This content isn’t available here
Access this content and more in the LinkedIn app
-
“If we’re truly to achieve good health for all and end the burden of major infectious diseases, we have to work together to understand, and react to, the ever-changing landscape. Together, we must adapt more quickly than ever before.” In our latest Behind the Science, GSK’s chief global health officer, Thomas Breuer, MD, MSc, shares his thoughts on how we can tackle two of biggest threats to global health progress – the effects of climate change on health as well as antimicrobial resistance (AMR) – and how we must work together to get things back on track: https://gsk.to/4e1Hcun #WHA77 #HealthForAll
-
Each year, more than 1 million people worldwide are diagnosed with a blood cancer. Today, on #WorldBloodCancerDay, we are raising awareness and showing support for the #bloodcancer community. Watch to learn more about two types of blood cancer: multiple myeloma and myelofibrosis.
-
GSK reposted this
To raise awareness of International Day Against LGBTQIA+ Discrimination, members of the #GSKAustralia SPECTRUM employee resource group set out to raise visibility in the workplace by encouraging everyone to ‘Go Rainbow.’ The day was also a great opportunity for us to come together as a group and reflect on how we can further our support for the LGBTQIA+ community within the workplace. Thank you to the entire SPECTRUM team for their ongoing work in helping us build a more inclusive workplace environment. Check out the team below and learn more about #IDAHOBIT here: https://lnkd.in/gJfDV_A